Lenalidomid Grindeks (Lenalidomide)

Lenalidomide binds to cereblon, a component of the CRL4‑E3 ubiquitin ligase complex, altering its substrate specificity. This leads to degradation of transcription factors such as Ikaros and Aiolos, resulting in anti‑angiogenic effects, modulation of cytokine release, enhanced immune cell activity, and direct inhibition of malignant cell growth.

The specific dose of Lenalidomid Grindeks is determined by the prescribing clinician based on the patient’s diagnosis, disease stage, renal function, and other clinical factors. Healthcare professionals set the appropriate regimen and adjust it as needed during treatment.

Lenalidomid Grindeks is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because of a high risk of fetal harm, including birth defects and miscarriage. It should not be used while breastfeeding, as it may be excreted in milk and affect the infant.

To request Lenalidomid Grindeks, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

The primary alternative to lenalidomide is thalidomide, another immunomodulatory drug. Compared with thalidomide, lenalidomide generally offers a more favorable safety profile, with lower rates of peripheral neuropathy, and provides stronger anti‑angiogenic and immune‑stimulating effects. Both agents share a similar mechanism but differ in potency and tolerability.

Lenalidomid Grindeks should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or other humid environments.

Lenalidomid Grindeks is administered orally, usually as a tablet taken with or without food as directed by the prescribing physician. The medication should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe neutropenia or other blood‑cell abnormalities that increase infection risk, hepatotoxicity indicated by elevated liver enzymes, secondary primary malignancies, and embryo‑fetal toxicity. Patients should be monitored closely for these events.

Lenalidomid Grindeks should not be used by pregnant women or women who could become pregnant without effective contraception, individuals with known hypersensitivity to lenalidomide or its excipients, and patients with severe renal or hepatic impairment unless dose adjustments are made under specialist supervision.